BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22669087)

  • 1. Nanomedicine: Downsizing tumour therapeutics.
    Cheng CJ; Saltzman WM
    Nat Nanotechnol; 2012 Jun; 7(6):346-7. PubMed ID: 22669087
    [No Abstract]   [Full Text] [Related]  

  • 2. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.
    Chauhan VP; Stylianopoulos T; Martin JD; Popović Z; Chen O; Kamoun WS; Bawendi MG; Fukumura D; Jain RK
    Nat Nanotechnol; 2012 Apr; 7(6):383-8. PubMed ID: 22484912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
    Huo M; Wang L; Chen Y; Shi J
    Nat Commun; 2017 Aug; 8(1):357. PubMed ID: 28842577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug delivery during pregnancy: how can nanomedicine be used?
    Joshi MD
    Ther Deliv; 2017 Dec; 8(12):1023-1025. PubMed ID: 29125062
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nanomedicine mechanical properties on tumor targeting delivery.
    Li Z; Xiao C; Yong T; Li Z; Gan L; Yang X
    Chem Soc Rev; 2020 Apr; 49(8):2273-2290. PubMed ID: 32215407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanomedicine: magnetic nanoparticles hit the target.
    Amirfazli A
    Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
    [No Abstract]   [Full Text] [Related]  

  • 15. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
    Powell AC; Paciotti GF; Libutti SK
    Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.
    de Maar JS; Sofias AM; Porta Siegel T; Vreeken RJ; Moonen C; Bos C; Deckers R
    Theranostics; 2020; 10(4):1884-1909. PubMed ID: 32042343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering the nanoparticle-protein interface for cancer therapeutics.
    Saie AA; Ray M; Mahmoudi M; Rotello VM
    Cancer Treat Res; 2015; 166():245-73. PubMed ID: 25895872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcellular transfer of nanomedicine.
    Jang HL; Sengupta S
    Nat Nanotechnol; 2019 Aug; 14(8):731-732. PubMed ID: 31263193
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics.
    Stapleton S; Dunne M; Milosevic M; Tran CW; Gold MJ; Vedadi A; Mckee TD; Ohashi PS; Allen C; Jaffray DA
    ACS Nano; 2018 Aug; 12(8):7583-7600. PubMed ID: 30004666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.